Anlon Healthcare came to market through an IPO that opened on 26 August 2025 and closed on 29 August 2025, and the shares listed on 3 September 2025 on BSE, NSE. The price band was ₹86 to ₹91 per share and one lot was 164 shares, so the minimum application was ₹14,924. The issue size was ₹121.03 crore. The whole issue was fresh shares, so the money raised went to the company.
Kfin Technologies Ltd was the registrar to the issue, and Interactive Financial Services Ltd was the lead manager.
As of 29 August 2025.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing firm involved in the production of Pharma Intermediates and active pharmaceutical ingredients (APIs).
The firm produces high-purity pharmaceutical intermediates (for API synthesis) and active pharmaceutical ingredients (utilized in formulations for pharmaceuticals, nutraceuticals, personal care, and animal health products).The firm deals in pharma intermediates, APIs for drugs, nutraceuticals, personal care, and veterinary products, all of which are produced to Indian and international pharmacopeia standards such as IP, BP, EP, JP, and USP.Besides producing Pharma Intermediates and APIs to international specifications, the firm now provides contract manufacturing of complex chemicals beyond purity levels and lowering impurities to suit particular customers' requirements.
The firm has been approved by ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs in terms of Drug Master File (DMF). The firm has submitted 21 DMFs to worldwide authorities and is submitting for Ketoprofen and Dexketoprofen Trometamol approvals.65 commercial products, 28 pilot-scale products, and 49 lab-scale products are part of the firm's portfolio. The firm maintains product quality through thorough testing, analysis, and process optimization.
Backed by four laboratories, the 34-strong team, which comprises 24 science graduates, guarantees that products meet customer and industry requirements.
As described in the offer document.
| Metric | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Punitkumar R. rasadia, Meet Atulkumar Vachhani, Mamata punitkumar Rasadia. Promoter holding 70.26% before the issue.
Work out the listing gain for this IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Anlon Healthcare IPO was a ₹121.03 crore book-built issue, made up entirely of a fresh issue. It was priced at ₹86–₹91 per share with a lot size of 164 shares (₹14,924). The IPO was open from August 26 to August 29, 2025 and was subscribed 7.12x. Shares listed on BSE and NSE on September 3, 2025 at ₹92, a 1.1% premium to the issue price of ₹91. Kfin Technologies Ltd is the registrar.
Interactive Financial Services Ltd is the book running lead manager.
The price band of Anlon Healthcare IPO is ₹86 to ₹91 per share.
The lot size of Anlon Healthcare IPO is 164 shares.
The minimum investment for Anlon Healthcare IPO is approximately ₹14,924 based on the upper price band.
The allotment date of Anlon Healthcare IPO is Sep 1, 2025.
Anlon Healthcare IPO's final recorded GMP before listing was ₹2 per share (a 2% premium over the ₹91 upper price band). The shares listed at ₹92. GMP is unofficial and does not forecast or guarantee the actual listing price.
Anlon Healthcare IPO listed on Sep 3, 2025. It was issued at ₹92.0(NSE) and is currently around ₹24.80 as on 2-Nov-2026 3:30 PM, which is approximately -72.7% versus issue price. The 52-week high is ₹37.24.
You can check Anlon Healthcare IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Anlon Healthcare IPO allotment status on Rupix for quick and easy access.
₹86 to ₹91 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 164 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,924.
₹14,924, for one lot of 164 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 26 August 2025 and closed on 29 August 2025.
The basis of allotment was published on 1 September 2025 by Kfin Technologies Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 3 September 2025 on BSE, NSE.
The issue size was ₹121.03 crore. The fresh issue was 1,33,00,000 shares (aggregating up to ₹121.03 crore).